Adiponectin, with its insulin-sensitising and anti-inflammatory properties, plays a crucial role in reducing risk of various cancers such as breast cancer [8,9], ovarian cancer [10], cervical cancer [11], endometrial cancer [12], colorectal cancer [13], and prostate cancer [14]. This evidence concerns the gene ADIPOQ and breast cancer.